Literature DB >> 23289676

Introduction: the challenge of nanomedicine human subjects research: protecting participants, workers, bystanders, and the environment.

Susan M Wolf1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23289676      PMCID： PMC4464664          DOI： 10.1111/j.1748-720X.2012.00702.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN： 1073-1105            Impact factor:   1.718


× No keyword cloud information.
  6 in total

1.  The emerging nanomedicine landscape.

Authors:  Volker Wagner; Anwyn Dullaart; Anne-Katrin Bock; Axel Zweck
Journal:  Nat Biotechnol       Date:  2006-10       Impact factor: 54.908

2.  What does the history of technology regulation teach us about nano oversight?

Authors:  Gary E Marchant; Douglas J Sylvester; Kenneth W Abbott
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

3.  An empirical examination of the current state of publically available nanotechnology guidance materials.

Authors:  Laura Fleege; Frances Lawrenz
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

4.  Designing Oversight for Nanomedicine Research in Human Subjects: Systematic Analysis of Exceptional Oversight for Emerging Technologies.

Authors:  Susan M Wolf; Cortney Jones
Journal:  J Nanopart Res       Date:  2011-04       Impact factor: 2.253

5.  Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.

Authors:  Leili Fatehi; Susan M Wolf; Jeffrey McCullough; Ralph Hall; Frances Lawrenz; Jeffrey P Kahn; Cortney Jones; Stephen A Campbell; Rebecca S Dresser; Arthur G Erdman; Christy L Haynes; Robert A Hoerr; Linda F Hogle; Moira A Keane; George Khushf; Nancy M P King; Efrosini Kokkoli; Gary Marchant; Andrew D Maynard; Martin Philbert; Gurumurthy Ramachandran; Ronald A Siegel; Samuel Wickline
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

Review 6.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products.

Authors:  Michael L Etheridge; Stephen A Campbell; Arthur G Erdman; Christy L Haynes; Susan M Wolf; Jeffrey McCullough
Journal:  Nanomedicine       Date:  2012-06-06       Impact factor: 5.307
  6 in total
  1 in total

Review 1.  Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.

Authors:  Fatemeh Farjadian; Amir Ghasemi; Omid Gohari; Amir Roointan; Mahdi Karimi; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2018-11-19       Impact factor: 5.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.